Rockville, Maryland — October 7, 2026 : Demand for viscosupplementation is set to rise as osteoarthritis prevalence, preference for minimally invasive treatment, and advances in hyaluronic acid formulations expand the addressable patient base. According to Fact.MR, the global viscosupplementation market is estimated at USD 6.2 billion in 2026 and is projected to reach USD 11.5 billion by 2036, advancing at a CAGR of 6.4% during the forecast period. The market is expected to create an absolute dollar opportunity of USD 5.3 billion between 2026 and 2036.

Get detailed market forecasts, competitive benchmarking, and pricing trends: 

More than 500 million people globally are affected by osteoarthritis, increasing the number of patients seeking conservative management options before joint replacement. Demand is also supported by the preference for non-surgical interventions and the growing adoption of single-injection products, which reduce clinic visits compared with traditional three- or five-injection regimens. Ultrasound-guided injection techniques are further improving the accuracy of intra-articular delivery and supporting treatment adoption.

Single Injection Viscosupplementation leads the product segment with a 38.6% share in 2026. Its strong position reflects established procurement channels and the convenience of completing a treatment course during one clinic visit. Biofermentation Derived Hyaluronic Acid accounts for 55.2% of the source segment, while Knee Osteoarthritis represents 46.8% of the application segment.

China is projected to record the fastest growth among the countries covered, advancing at a 7.9% CAGR through 2036. Its expansion is supported by osteoarthritis prevalence, an aging population, increasing orthopedic procedure volumes, and growing hospital capacity in tier-1 and tier-2 cities. India follows with a 7.5% CAGR, driven by knee osteoarthritis prevalence, expanding orthopedic specialty capacity, and patient preference for non-surgical treatment. Germany is expected to expand at 5.7% CAGR, supported by established orthopedic practice, insurance coverage, and outpatient healthcare infrastructure.

Unlock 360° insights for strategic decision making and investment planning: 

The competitive landscape includes Zimmer Biomet Holdings, Inc., DePuy Synthes, Fidia Farmaceutici S.p.A., Sanofi S.A., and Smith & Nephew plc. Competition is influenced by single- versus multi-injection formats, hyaluronic acid formulation characteristics, clinical evidence, and relationships with orthopedic prescribers.

Fact.MR’s viscosupplementation market report provides detailed forecasts across product, source, application, end use, and regional markets, helping manufacturers, healthcare providers, investors, and procurement teams assess emerging opportunities through 2036.

Explore More Related Studies Published by Fact.MR Research

Non-Invasive Diagnostic Tests Market

Disposable Spirometry Filters Market

Dual-Chamber Cartridge Plungers Market

Elastomeric Pump Cartridges Market

CPAP Humidifier Chambers Market

About Fact.MR

Fact.MR is a market research and consulting firm providing syndicated research, customized research, investment research, and market intelligence across a broad range of industries. Its research coverage includes food and beverage, healthcare, pharmaceuticals, biotechnology, consumer products, chemicals and materials, technology, industrial goods, and packaging.

Fact.MR provides market intelligence designed to help organizations understand market dynamics, emerging opportunities, competitive developments, and changing industry requirements.

Media Contact

Fact.MR
Email: sales@factmr.com
Phone: +1 (628) 251-1583
Website: www.factmr.com